Quetiapine Fumarate
Quetiapine Fumarate is an atypical antipsychotic drug that interacts with a broad range of neurotransmitter receptors. It exhibits affinity for brain serotonin (5-HT2) and dopamine (D1 and D2) receptors, helping to restore the balance of certain natural chemicals in the brain.
Dosage by Body Weight
Dosage must be individualized and titrated under strict medical supervision. Typical adult daily doses range from 150 mg to 800 mg depending on the indication. XR tablets should be swallowed whole, without food or with a light meal, usually once daily at bedtime. Immediate-release tablets are typically taken twice daily.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy are not established in infants.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy are not established in infants and toddlers.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Not indicated for pediatric patients in this weight range.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Pediatric use is restricted to older children and adolescents for specific indications.
- Body Weight
- 16-20 kg
- Dose
- Not routine
- Frequency
- Use only if explicitly prescribed
- Tracking Notes
- Approved only for schizophrenia in adolescents (13-17 years) and bipolar mania in children/adolescents (10-17 years). Must be managed by a pediatric psychiatrist.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | Do not use | Safety and efficacy are not established in infants. |
| 5-7 kg | Not recommended | Do not use | Safety and efficacy are not established in infants and toddlers. |
| 8-10 kg | Not recommended | Do not use | Not indicated for pediatric patients in this weight range. |
| 11-15 kg | Not recommended | Do not use | Pediatric use is restricted to older children and adolescents for specific indications. |
| 16-20 kg | Not routine | Use only if explicitly prescribed | Approved only for schizophrenia in adolescents (13-17 years) and bipolar mania in children/adolescents (10-17 years). Must be managed by a pediatric psychiatrist. |
Formulation
Purpose
Treatment of schizophrenia, bipolar disorder (including manic, depressive, and mixed episodes), and major depressive disorder as an add-on treatment.
Generic Name
Quetiapine FumarateBranded Drug Names
Quetiapine Fumarate is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.